【US Stock Movements】Grail surged on October 9: Regulatory support, Galleri data, and growth in testing
Bitget异动解读2026/10/09 14:05Grail October 9th Surge Interpretation
Keywords: Regulatory Support, Galleri Data, Detection Growth
1. On September 23rd, the FDA Medical Devices Advisory Committee voted 10 to 0 on the safety of Galleri, 7 to 2 that the benefits outweigh the risks, and 6 to 4 on its effectiveness, providing regulatory progress for subsequent PMA review.
2. From October 6th to 8th, GRAIL presented six sets of data at EDCC regarding Galleri's clinical performance, health equity, and real-world applications, including detection of more than 200 types of cancer and determination of cancer signal sources.
3. As of June 30th, Galleri's testing volume in the first half of the year increased by 42% year-on-year to over 117,000 tests; the company mainly focuses on early detection of multiple cancer types, with Galleri as a commercialized blood screening product.
(Disclaimer: This content is summarized from publicly available information using AI technology and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Stock Movement | Snap (SNAP.US) rises over 6% as hedge funds urge the introduction of external capital for Specs, potentially unlocking shareholder value
According to news from Zhitong Finance APP, on Friday, Snap (SNAP.US) surged over 6% to $6.24. On the news front, the hedge fund Blue Duck Capital Partners hopes that Snap Inc. will sell part of its Specs business shares to raise funds. Alex Beinfield, Chief Investment Officer of Blue Duck, recently said in a letter to Snap’s board that Snap is "seriously" undervalued, and raising funds for Specs would unlock significant shareholder value. He stated that a financing centered on Specs would help support related expenditures without diluting Snap's share count, while also preserving its cash flow. Moreover, this move is expected to help the company reduce the Specs’ price of about $2,200. He believes that selling 20% of the Specs subsidiary at a valuation of $5 billion would raise $1 billion, enough to support that department's expenses for around two years.
AI data center company Firmus, backed by Nvidia (NVDA.US), cancels IPO amid doubts over its $30 billion valuation and insufficient demand from U.S. investors
According to Zhihui Finance APP, Firmus Grid, an Australian artificial intelligence (AI) data center operator backed by Nvidia (NVDA.US), originally planned to go public with a valuation of around 30 billions USD, which would have made it one of Australia's largest initial public offerings (IPO). However, due to overvaluation, insufficient investor subscription demand, and concerns in the market regarding the massive financing needs of AI infrastructure, this high-profile IPO was ultimately canceled on Friday.
Crypto prices
More
